Section Arrow
TMDX.NASDAQ
- TransMedics Group
Quotes are at least 15-min delayed:2025/06/28 13:16 EDT
Last
 131.45
+1.39 (+1.07%)
Day High 
133.02 
Prev. Close
130.06 
1-M High
145.5 
Volume 
623.72K 
Bid
129.64
Ask
131.25
Day Low
129.66 
Open
130.79 
1-M Low
120.3 
Market Cap 
4.40B 
Currency USD 
P/E 92.1 
%Yield -- 
10-SMA 133.05 
20-SMA 133.28 
50-SMA 116.12 
52-W High 177.37 
52-W Low 55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.42/2.75
Enterprise Value
4.92B
Balance Sheet
Book Value Per Share
7.87
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
23.60M
Operating Revenue Per Share
5.67
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 13:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.